releases: https://roe.house.gov/news/documentsingle.aspx?DocumentID=400683
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://roe.house.gov/news/documentsingle.aspx?DocumentID=400683 | Roe Supports Policies That Result In More Cures Not Less | 2019-12-12 | 2019 | 2019-12 | Republican | House | TN | Phil Roe | R000582 | roe.house.gov | legacy | WASHINGTON, D.C.- Today, Rep. Phil Roe (R-Tenn.) released the following statement after voting against H.R. 3, the so-called Lower Drug Costs Now Act: I have lost loved ones to cancer while waiting for a cure and I don't want to lose another one. That is why I could not support H.R. 3. There is no question the cost of prescription drugs is too high, but this misguided bill would effectively give government bureaucrats the power to set drug prices. This will stifle innovation and some estimates say this bill could prevent 100 new treatments and cures from being developed. The United States leads the way in creating new cures that saves lives globally, and discouraging innovation would be catastrophic. That is why I support H.R. 19, the Lower Costs More Cures Act. This bipartisan legislation will help lower the cost of prescription drugs without restricting innovation by improving price transparency, preventing drug manufacturers from stalling development of generics, and giving the FDA the authority to approve multiple generics to stir competition.I will not apologize for rejecting a policy that would result in fewer cures, and I will continue working with my colleagues to fight for bipartisan legislation that encourages innovation to save lives. Note: Watch Congressman Roe's floor remarks on H.R. 3here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |